Trellus Health plc
TRLHF
$0.015
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 257.14% | 257.14% | -37.50% | -37.50% | 40.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 257.14% | 257.14% | -37.50% | -37.50% | 40.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 257.14% | 257.14% | -37.50% | -37.50% | 40.00% |
| SG&A Expenses | 9.06% | 9.06% | -35.94% | -35.94% | -22.41% |
| Depreciation & Amortization | -- | -- | 29.10% | 29.10% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.06% | 9.06% | -26.90% | -26.90% | -22.41% |
| Operating Income | -8.14% | -8.14% | 26.88% | 26.88% | 22.54% |
| Income Before Tax | -9.08% | -9.08% | 30.18% | 30.18% | 26.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.08% | -9.08% | 30.18% | 30.18% | 26.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.08% | -9.08% | 30.18% | 30.18% | 26.30% |
| EBIT | -8.14% | -8.14% | 26.88% | 26.88% | 22.54% |
| EBITDA | -8.21% | -8.21% | 27.10% | 25.87% | 23.03% |
| EPS Basic | -9.09% | -9.09% | 30.08% | 30.08% | 26.67% |
| Normalized Basic EPS | -8.70% | -8.70% | 33.78% | 33.78% | 26.60% |
| EPS Diluted | -9.09% | -9.09% | 30.08% | 30.08% | 26.67% |
| Normalized Diluted EPS | -8.70% | -8.70% | 33.78% | 33.78% | 26.60% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |